Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-13-012171
Filing Date
2013-02-27
Accepted
2013-02-27 18:16:59
Documents
1
Period of Report
2013-02-25

Document Format Files

Seq Description Document Type Size
1 MAIN DOCUMENT DESCRIPTION c494003_4x0.html 4  
1 MAIN DOCUMENT DESCRIPTION c494003_4x0.xml 4 4670
  Complete submission text file 0001209191-13-012171.txt   5999
Mailing Address 91 JAMES AVENUE ATHERTON CA 94027
Business Address
KING THOMAS BRAXTON (Reporting) CIK: 0001279309 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-51820 | Film No.: 13648348

Mailing Address 2091 STIERLIN COURT MOUNTAIN VIEW CA 94043
Business Address 2091 STIERLIN COURT MOUNTAIN VIEW CA 94043 650.944.7000
Alexza Pharmaceuticals Inc. (Issuer) CIK: 0001344413 (see all company filings)

EIN.: 770567768 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations